Inversago Pharma Revenue and Competitors

Claim your profile

Montreal, QC CAN

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Inversago Pharma's estimated annual revenue is currently $2.6M per year.(i)
  • Inversago Pharma's estimated revenue per employee is $100,500

Employee Data

  • Inversago Pharma has 26 Employees.(i)
  • Inversago Pharma grew their employee count by -10% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$2.4M12-8%N/AN/A
#2
$10.7M1005%$39.7MN/A
#3
$47.8M238N/AN/AN/A
#4
$15.5M775%N/AN/A
#5
$345.9M17218%N/AN/A
#6
$167M8318%N/AN/A
#7
$318.8M15867%N/AN/A
#8
$27.5M137-26%N/AN/A
#9
$0.4M40%N/AN/A
#10
$66.9M333N/AN/AN/A
Add Company

Located in Montreal, Inversago Pharma is a privately-owned Canadian biotech company at clinical-stage, specialized in the development of new therapies focusing on CB1 blockade, based on first-in-class, peripherally-acting, CB1 inverse agonists. The Company aims to provide new treatment options that improve the lives of patients affected by metabolic conditions such as diabetic nephropathy, Non-Alcoholic Steatohepatitis (NASH), complications of obesity, hypertriglyceridemia (HTG) and Type 1 Diabetes (T1D), Prader-Willi Syndrome (PWS), as well as fibrotic indications such as Progressive Fibrosis – Interstitial Lung Disease (PF-ILD), including Idiopathic Pulmonary Fibrosis (IPF).

keywords:N/A

N/A

Total Funding

26

Number of Employees

$2.6M

Revenue (est)

-10%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.6M26N/AN/A
#2
$2.4M2630%N/A
#3
$4.6M2618%N/A
#4
N/A264%N/A
#5
$2.6M268%N/A